Essex Bio-technology Overview
- Founded
-
2000

- Status
-
Public
- Employees
-
1,379

- Stock Symbol
-
01061

- Investments
-
5
- Share Price
-
$0.45
- (As of Thursday Closing)
Essex Bio-technology General Information
Description
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is primarily made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
HKG
Primary Office
- Room 2818, China Merchants Tower
- Shun Tak Centre, 168-200 Connaught Road Central
- Hong Kong
- Hong Kong
+852 2587 0000
Essex Bio-technology Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.45 | $0.46 | $0.41 - $1.07 | $259M | 575M | 199K | $0.08 |
Essex Bio-technology Financials Summary
In Thousands, USD |
TTM 31-Dec-2021 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 352,948 | 352,948 | 301,099 | 452,287 |
Revenue | 210,688 | 210,688 | 126,094 | 163,289 |
EBITDA | 54,908 | 54,908 | 35,103 | 48,870 |
Net Income | 44,509 | 44,509 | 28,223 | 38,606 |
Total Assets | 367,199 | 367,199 | 312,336 | 266,793 |
Total Debt | 72,478 | 72,478 | 72,594 | 47,415 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Essex Bio-technology Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic
Pharmaceuticals
Hong Kong, Hong Kong
1,379
As of 2021
Essex Bio-technology Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
00000 00000000 000 | Private Equity-Backed | Beijing, China | 0000 | 00000 | 000000000000 | 00000 |
Essex Bio-technology Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Hian Leng Ngiam | Board Member & Executive | ||
Mia Je Ngiam | Chairman & Board Member |
Essex Bio-technology Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
0000 0000 00000 | Essex Bio-technology | Board Member & Executive | 000 0000 |
000 0000 0000 | Essex Bio-technology | Board Member | 000 0000 |
000 00 00000 | Essex Bio-technology | Chairman & Board Member | 000 0000 |
0000000 00000 | Essex Bio-technology | Chairman | 000 0000 |
Essex Bio-technology Signals
Essex Bio-technology Investments (5)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 000 | 30-Aug-2019 | 00000 0000 | 0000 | Drug Discovery | 0000000 0 |
00000000 000 | 28-Aug-2018 | 00000 0000 | 0000 | Drug Discovery | 0000000 0 |
0000000000000 | 22-Aug-2018 | 00000 0000 | 00.000 | Decision/Risk Analysis | |
00 000000 | 09-May-2016 | 00000 0000 | 000.00 | Drug Discovery | |
Abpro | 06-Apr-2016 | Later Stage VC | 000.00 | Drug Discovery | 0000000 0 |
Essex Bio-technology Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
00 000000 | 09-May-2016 | 00000 00000 00 | 000.00 | Completed |
|